Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort.

Antonino Lupica Vincenzo Di Stefano Salvatore Iacono Antonia PignoloMartina QuartanaAndrea GagliardoBrigida FierroFilippo Brighina

Published in: Neurology international (2022)

COVID-19 significantly impacted MG patients with an increase in mortality due to respiratory sequelae. Vaccines against SARS-CoV-2 showed good short-term safety in MG patients, who may take advantage of vaccination to avoiding life-threatening complications such as COVID-19 pneumonia.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
myasthenia gravis
risk factors
big data
coronary artery disease
deep learning
acute respiratory distress syndrome
respiratory failure
data analysis